Jeremy Blachman Livres

The data revolution is reshaping biotech and health care, particularly in the wake of COVID-19, offering new opportunities to enhance patient outcomes and organizational efficiency. This work explores the evolution of life sciences and health care, providing essential insights and strategies for scientists, physicians, executives, and patients to navigate this transformative landscape. A significant challenge for biotech, pharma, and medical device companies is integrating new knowledge and technologies to deliver the right treatments to patients at the right times, a task made more urgent by the pandemic. Through compelling stories of innovative businesses and individuals—from a fertility-tracking device to a novel diabetes treatment—key breakthroughs and practical techniques are highlighted to help companies stay competitive and deliver solutions more effectively while adhering to traditional therapeutic principles. The text discusses advancements in precision medicine for cancer and rare diseases, the role of data and digital technologies in developing effective disease management platforms, and how value-based reimbursement is altering the life sciences business model. With the right incentives, outcomes can improve at every stage of the patient journey. This essential roadmap is a call to action for all stakeholders in health care to seize the moment and drive meaningful change.

This is the story of a hiring partner at one of the world's largest law firms, who has just started a web-blog to tell the world what life is really like at the top of his profession. The story rips away the bland facade of corporate law and offers a telling glimpse inside a frightening world.